Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (Jiangsu Watson Biotechnology)

四价流感病毒裂解疫苗（江苏沃森）

Report date: 2024/10/15 20:00:08

Base Information

Drug NameInfluenza Vaccine (Split Virion), Inactivated, Quadrivalent (Jiangsu Watson Biotechnology)

Drug Alias NameN/A

ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesJiangsu Huanuotai Biomedical Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A